Physician

Allan W Silberman, M.D.

According to 2025 Medicare claims, Allan Silberman, M.D. (NPI: 1265456560) practices surgical oncology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CEDARS-SINAI MEDICAL CENTER (NPI: 1639172372; TIN: 951644600) and primary practice location at 90048-1804.

Silberman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 182 traditional Medicare patients, billed 449 HCPCS/CPT codes, and received $61,481 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 377 prescription claims across 44 beneficiaries totaling $35,329 in drug costs, led by Xarelto (Rivaroxaban). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $117,663 to $61,481. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $17,459 and ending at $35,329. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,495 to $362.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$59K$118K2015 Medicare payment: $117,663 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $108,761 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $98,734 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $89,021 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $74,660 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $52,312 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $54,976 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $58,690 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $55,649 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $61,481 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015233630$117,663
2016245630$108,761
2017254668$98,734
2018229559$89,021
2019214530$74,660
2020179385$52,312
2021187446$54,976
2022174410$58,690
2023187453$55,649
2024182449$61,481

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$18K$37K2015 Drug cost: $17,459 (USD; Tot_Drug_Cst)2016 Drug cost: $21,133 (USD; Tot_Drug_Cst)2017 Drug cost: $11,447 (USD; Tot_Drug_Cst)2018 Drug cost: $15,678 (USD; Tot_Drug_Cst)2019 Drug cost: $36,557 (USD; Tot_Drug_Cst)2020 Drug cost: $27,683 (USD; Tot_Drug_Cst)2021 Drug cost: $16,864 (USD; Tot_Drug_Cst)2022 Drug cost: $11,499 (USD; Tot_Drug_Cst)2023 Drug cost: $23,467 (USD; Tot_Drug_Cst)2024 Drug cost: $35,329 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201537218$17,459
201647249$21,133
201748225$11,447
201844215$15,678
201951303$36,557
202054323$27,683
202143216$16,864
202237177$11,499
202352244$23,467
202444377$35,329

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more2727$144
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more153280$51
99231Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes1245$42

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XareltoRivaroxaban13390$7,424
PremarinEstrogens, Conjugated11170$1,108
Pantoprazole SodiumPantoprazole Sodium914,740$756
AnastrozoleAnastrozole251,080$631
Potassium ChloridePotassium Chloride13374$179

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Allan W. Silberman, M.D.?

Tedicare shows public-source Medicare data for Allan W. Silberman, M.D. (NPI 1265456560), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allan W. Silberman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Allan W. Silberman, M.D.?

Allan W. Silberman, M.D. is linked to CEDARS-SINAI MEDICAL CENTER (billing NPI 1639172372) in the available physician profile data.

Does Allan W. Silberman, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.